CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy

被引：2
|
作者：
Wilton-Clark, Harry [1 ]
Yokota, Toshifumi [1 ]
机构：
[1] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada
来源：
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 2023年 / 30卷
关键词：
D O I：
10.1016/j.omtm.2023.08.013
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：500 / 501
页数：2
相关论文
共 50 条
  • [41] Antisense-mediated exon skipping as a gene correction therapy for Duchenne muscular dystrophy
    van Deutekom, J
    Aartsma-Rus, A
    Bremmer-Bout, M
    Janson, A
    den Dunnen, J
    van Ommen, GJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S75 - S76
  • [42] Optimization of antisense-mediated exon skipping in mouse models for Duchenne muscular dystrophy
    Aartsma-Rus, A.
    Heemskerk, H. A.
    de Winter, C. L.
    van Putten, M.
    De Kimpe, S.
    van Deutekom, J. C. T.
    van Ommen, G. J. B.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 757 - 757
  • [43] Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy
    Yokota, Toshifumi
    Pistilli, Emidio
    Duddy, William
    Nagaraju, Kanneboyina
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (06) : 831 - 842
  • [44] U7snRNA-Mediated Exon 17 Skipping in Duchenne Muscular Dystrophy
    Gushchina, Liubov V.
    Dufresne, Gabrielle
    Saylam, Ezgi
    Bradley, Adrienne
    Rohan, Natalie
    Lowery, Allison
    Lin, Hui
    Wein, Nicolas
    Flanigan, Kevin M.
    MOLECULAR THERAPY, 2024, 32 (04) : 701 - 701
  • [45] Systemic Antisense-Mediated Exon Skipping in Mouse Models for Duchenne Muscular Dystrophy
    Aartsma-Rus, Annemieke
    Heemskerk, Hans
    De Winter, Christa
    Van Putten, Maaike
    Janson, Anneke
    Verschuuren, Jan
    Den Dunnen, Johan
    Van Deutekom, Judith
    Van Ommen, Gert-Jan
    MOLECULAR THERAPY, 2009, 17 : S166 - S166
  • [46] Beyond clinical trials for antisense-mediated exon skipping for Duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    HUMAN GENE THERAPY, 2014, 25 (11) : A13 - A13
  • [47] Current Outline of Exon Skipping Trials in Duchenne Muscular Dystrophy
    Eser, Gokce
    Topaloglu, Haluk
    GENES, 2022, 13 (07)
  • [48] Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
    Kemaladewi, Dwi U.
    Hoogaars, Willem M. H.
    van Heiningen, Sandra H.
    Terlouw, Samuel
    de Gorter, David J. J.
    den Dunnen, Johan T.
    van Ommen, Gert Jan B.
    Aartsma-Rus, Annemieke
    ten Dijke, Peter
    't Hoen, Peter A. C.
    BMC MEDICAL GENOMICS, 2011, 4
  • [49] EXON SKIPPING AND DUCHENNE MUSCULAR DYSTROPHY: A CLINICAL TRIAL UPDATE
    Wilton, Steve
    Fletcher, Sue
    JOURNAL OF GENE MEDICINE, 2013, 15 (8-9): : 330 - 330
  • [50] The Status of Exon Skipping as a Therapeutic Approach to Duchenne Muscular Dystrophy
    Lu, Qi-Long
    Yokota, Toshifumi
    Takeda, Shin'ichi
    Garcia, Luis
    Muntoni, Francesco
    Partridge, Terence
    MOLECULAR THERAPY, 2011, 19 (01) : 9 - 15
12345